Home › Trial NCT02161770
Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
- Trial IDNCT02161770
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAstraZeneca
- Enrollment30
- Start date2014-12-22
- ConditionsSolid Tumours
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.